CURRENT PREVENTION STRATEGIES FOR INFLUENZA VIRUS INFECTION: EVIDENCE, PRACTICE, AND THE ROLE OF MATERNAL VACCINATION
Open Access
- 22 September 2025
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(47))
Abstract
Background: Seasonal influenza remains a major cause of morbidity and mortality in Europe. Prevention relies primarily on vaccination, supported by non-pharmaceutical interventions (NPIs) and surveillance. Pregnant women are a key target group, as maternal immunization protects both mother and infant. Methodology: A narrative review of recent PubMed-indexed studies, complemented by European Centre for Disease Prevention and Control (ECDC) reports and national data from Poland, was undertaken. Evidence on vaccine effectiveness, safety of maternal immunization, vaccination coverage, and the role of NPIs was synthesized. Results: Influenza vaccine effectiveness in Europe has been moderate, ranging from 32–55% depending on subtype and season, with highest protection against influenza B and lowest against A(H3N2). Maternal vaccination provides significant protection for infants under six months, particularly when administered in the third trimester, and shows no association with adverse pregnancy outcomes. Despite strong evidence, vaccine uptake in Poland remains among the lowest in Europe, with only about 10% coverage in older adults and minimal uptake among pregnant women. NPIs, including mask use and hand hygiene, reduce transmission and are particularly valuable in seasons of poor vaccine match. Discussion: Vaccination is the cornerstone of influenza prevention, yet insufficient coverage undermines its impact. Maternal immunization remains underutilized, while NPIs provide important complementary protection. Barriers include cost, misinformation, and logistical challenges. Conclusions: Effective influenza prevention requires higher vaccine uptake, integration of maternal immunization into routine prenatal care, selective use of NPIs, and stronger surveillance. Without systemic improvements, the potential of influenza prevention cannot be fully realized.Keywords
This publication has 16 references indexed in Scilit:
- Non-pharmaceutical interventions to reduce influenza transmission in households: a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2024
- Safety of the Seasonal Influenza Vaccine in 2 Successive PregnanciesJAMA Network Open, 2024
- Maternal Vaccine Effectiveness Against Influenza-Associated Hospitalizations and Emergency Department Visits in InfantsJAMA Pediatrics, 2024
- Uptake of COVID-19 and influenza vaccines in relation to preexisting chronic conditions in the European countriesBMC Geriatrics, 2024
- Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre studyInfluenza and Other Respiratory Viruses, 2024
- Maternal immunization with distinct influenza vaccine platforms elicits unique antibody profiles that impact the protection of offspringbioRxiv, 2023
- Safety of influenza vaccination during pregnancy: a systematic reviewBMJ Open, 2023
- Vaccination programs for pregnant women in Europe, 2021Vaccine, 2021
- Efficacy and safety of influenza vaccination during pregnancy: realizing the potential of maternal influenza immunizationExpert Review of Vaccines, 2021
- Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden – a systematic reviewJournal of Infection, 2020